DNA-mismatch repair removes mismatches from the newly replicated DNA strand. In humans, mutations in the mismatch repair genes hMSH2, hMLH1, hPMS1 and hPMS2 result in hereditary non-polyposis colorectal cancer (HNPCC) 
Results and discussion
MSH2 and MSH2-MSH3 were purified to near homogeneity from extracts prepared from yeast strain LY2 harboring plasmids pPM608, and pMMR8 and pMMR20, respectively (Fig. 1) . The identity of the MSH2 and MSH3 proteins was verified by immunoblotting with specific affinity-purified antibodies (data not shown). Densitometric scanning of Coomassie blue stained SDS-PAGE gels showed that the purified complex contained an equimolar ratio of MSH2 and MSH3. During purification, MSH2-MSH3 remained tightly associated in column fractions that contained as little as 5 × 10 -9 M of the complex, indicating that the dissociation constant of the heterodimer must be significantly lower than this concentration.
We carried out mobility-shift experiments to examine binding of purified MSH2 and MSH2-MSH3 to 32 P-labeled DNA duplexes containing a loop that was 2, 4, 8 or 14 nucleotides in length (designated +2, +4, +8 and +14, respectively) and located in the middle of the duplexes (Fig.  2a) . Purified MSH2-MSH3 bound to all four loop-containing substrates, as indicated by their delayed migration (Fig.  2b) ; no binding to the G/C control homoduplex occurred (Fig. 2b) . The amount of nucleoprotein complex formed between MSH2-MSH3 and the DNA substrate increased with the size of the extrahelical loop (Fig. 2b) . Phosphoimage analysis of the gel shown in Figure 2b revealed that MSH2-MSH3 bound to 3 %, 17 %, 25 % and 68 % of the +2, +4, +8 and +14 substrates, respectively (Fig. 2c ). In contrast, MSH2 alone, at four times the molar amount of the MSH2-MSH3 heterodimer, did not bind to any of the DNA substrates used (Fig. 2b,c) . Thus, recognition of the extrahelical loop requires that MSH2 is complexed with MSH3. Binding of the +2 and +4 substrates by MSH2-MSH3 was proportional to the amount of heterodimer (Fig. 2d) .
In both yeast and humans, MSH2 also combines with the MSH6 (GTBP) protein, and the heterodimeric complex binds a G/T mismatch. Genetic studies in yeast have suggested that MSH3 acts with MSH2 to remove insertion/ deletion mismatches but may have little or no role in removing base-base mismatches [12, 13, 15] . It was therefore important to compare the relative affinities of the purified MSH2-MSH3 complex for extrahelical loops and for a G/T mismatch. The results shown in Figure 3 indicate that MSH2-MSH3 had low affinity for the G/T mismatch, as only <1 % of the G/T-containing substrate was bound by an amount of the protein complex sufficient to shift >20 % of the +4 substrate, ∼6 % of the +2 substrate, and ∼2.5 % of a substrate that contained one extrahelical base (designated +1; see Fig. 2a ). It was already established that MSH2 alone did not bind to the +2 or the +4 substrates (Fig. 2b,c) ; we also found that MSH2 did not bind to the G/T mismatch or the +1 substrate (data not shown).
The relative affinities of MSH2-MSH3 for extrahelical loops versus the G/T mismatch were further examined in a competition experiment (see Materials and methods). The results showed that, although a 15-fold molar excess of the unlabelled +4 and +14 substrates reduced binding of MSH2-MSH3 to a 32 P-labeled +4 substrate by ∼70 % and 90 %, respectively, as much as a 60-fold excess of G/T-containing substrate reduced binding to the +4 substrate by only ∼10 % (data not shown). Taken together, our data indicate that MSH2-MSH3 has low affinity for a G/T mismatch, and that it specifically recognizes loops, with the affinity for the latter increasing with the size of the extrahelical loop. Binding of hMutS␣ and the yeast equivalent of this heterodimer to a G/T mismatch is highly sensitive to ATP, which induces a large reduction in nucleoprotein complex formation [9, 14] . The mismatch-binding properties of MSH2-MSH3, however, were not affected by ATP (data not shown). Thus, in contrast to hMutS␣, MSH2-MSH3 does not recognize G/T mispairs and binding of MSH2-MSH3 to loops is insensitive to ATP. microsatellite tract instability [12, 13] . In contrast, mutations in MSH3 have a more prominent effect on tract instability [12, 15] . From these and other observations, it has been surmised that MSH2-MSH3 is more proficient at removing loops of two and more nucleotides [12] , whereas MSH2-MSH6 is better at removing single-base mismatches [12, 13] . That human cell lines defective in the MSH6 component of hMutS␣ exhibit a selective loss in the repair of base-base mismatches and single-nucleotide loops [9, 11] supports this idea. Our results provide direct evidence that MSH2-MSH3 does bind to loops but shows little affinity for G/T mispairs. In contrast, human hMutS␣ and yeast MSH2-MSH6 bind efficiently to a G/T mismatch [9, 14] . In addition, hMutS␣ has been shown to bind to one and three nucleotide loops [9] , consistent with the observation that mutations in the yeast or human MSH6 gene also cause some reduction in the repair of loops between two and four nucleotides in length [9, 12] .
Materials and methods

Polyclonal antibodies specific for MSH2 and MSH3
The nucleotide sequence encoding amino-acids 374-547 of MSH2 was fused to that encoding the 15 amino-terminal residues of the E. coli transcriptional terminator , yielding plasmid pPM552. The sequence encoding residues 210 to 734 of MSH3 was fused to that encoding the 321 amino-terminal residues of to yield pPM477. These plasmids were introduced into E. coli strain AR120.A6 and expression of the -MSH2 and -MSH3 hybrid proteins, which was driven by the P L promoter, was induced with nalidixic acid. Both fusion proteins were insoluble and were purified by preparative SDS-PAGE in order to raise polyclonal antibodies in rabbits, and to prepare affinity matrices for purification of antibodies from immune sera [16] .
Plasmids for overproduction of MSH2 and MSH3 in yeast
The MSH2 gene from the ATG initiating codon to 259 bases downstream of the TAA stop codon was placed under the control of the synthetic hybrid galactoseinducible GAL-PGK promoter, generating pPM608. MSH2 was also placed under the control of the constitutive ADC1 promoter, generating pMMR8. The MSH3 gene from position -6 relative to the ATG initiating codon to 169 bases downstream of the TGA stop codon was placed under the inducible GAL-PGK promoter to give pMMR20.
Purification of MSH2 and the MSH2-MSH3 complex
The first two column chromatographic steps in PBE 94 and Bio-Rex 70 were adapted from the MSH2 purification protocol [17] . For MSH2, extract was prepared from 100 g of yeast strain LY2 [18] harboring pPM608 in 250 ml buffer A (25 mM Tris-HCl (pH 7.6), 2 mM EDTA and 10 mM ␤-mercaptoethanol) containing 250 mM NaCl, using a French press. The crude lysate was clarified by centrifugation (100 000 × g, 120 min), and applied onto a PBE 94 column (2.5 × 8 cm), which was eluted with a 600 ml gradient of 250-500 mM NaCl. Fractions containing MSH2, eluting at ∼380 mM NaCl, were pooled, dialyzed against buffer A plus 100 mM NaCl, and loaded onto a Bio-Rex 70 column (1 × 5 cm), which was developed with a 60 ml gradient of 240-500 mM NaCl. Peak fractions were pooled, concentrated to 0.4 ml and fractionated in a Sephacryl S300 (1 × 44 cm) column in buffer A containing 50 mM NaCl. MSH2-containing fractions were pooled and further purified in a Source 15 Q (0.5 ml matrix packed in an HR5/2 column; Pharmacia) with a 15 ml gradient of 50-350 mM NaCl. MSH2 protein eluted from Source Q at ∼280 mM NaCl, the peak of which was concentrated in a Centricon-30 microconcentrator (Amicon). For purification of MSH2-MSH3, 400 g of yeast strain LY2 harboring pMMR8 and pMMR20 was clarified by centrifugation and fractionated in PBE 94 and Bio-Rex 70 as described above. The MSH2-MSH3 protein pool from Bio-Rex 70 was dialyzed against buffer A plus 50 mM NaCl and then fractionated in a 1 ml Bio-Gel HTP hydroxyapatite column with a 20 ml gradient of 0-400 mM KH 2 PO 4 . The peak of MSH2-MSH3, eluting at ∼280 mM KH 2 PO 4 , was diluted with three volumes of buffer A and fractionated in a 0.5 ml Source 15 Q column with a 20 ml gradient of 50-400mM NaCl. MSH2-MSH3 eluted from Source 15 Q at ∼300 mM NaCl, and was concentrated as described above.
Mobility shift assay
The bottom strand of each substrate (Fig. 2a) was labeled with ␥-[ 32 P]ATP and T4 polynucleotide kinase. The DNA substrates, all with the same specific radioactivity (2 ng; 1 × 10 4 cpm), were incubated for 5 min at 25 o C with MSH2 or MSH2-MSH3 and 80 ng of HaeIII-digested X174 dsDNA in 10 l reaction buffer (25 mM Tris-HCl (pH 8.0), 1 mM MgCl 2 , 50 mM KCl, 1 mM DTT, 50 g ml -1 BSA and 10 % glycerol). The samples were mixed with 3 l of loading buffer (50 mM Tris-HCl (pH 7.5), 3 mM EDTA and 50 % glycerol) and subjected to electrophoresis (30 mA, 1 h) at 4 o C in 0.75 mm thick 4 % polyacrylamide gels in 40 mM Tris-acetate (pH 7.5) containing 2 mM EDTA. Gels were dried and exposed to X-ray films or subjected to analysis in a Phosphoimager (Molecular Dynamics). For competition experiments, 100 ng of MSH2-MSH3 was incubated with the 32 P-labeled +4 loop substrate in the presence of various amounts of the different unlabelled competitors.
